On the stock market since 1994, it operates in the world of health and science. It has 4 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 71% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $2.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 29% a year on average.
There is $2.6M in the vault; even if every debt were paid off, $2.6M would remain.
It pays out $0.05 per share each year — regular cash for whoever holds the stock.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
On our five-subject report card, NTII sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: NTII is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.